It has been nearly 60 years since the European Union (EU) established pharmaceutical legislation following the thalidomide scandal, which caused birth defects in an estimated 20,000 children, to ensure that new medicines are authorised as safe, efficacious and of good quality. 

Now, the European Commission has published its proposed reform ...